Pindolol augmentation of antidepressant treatment: recent contributions from brain imaging studies (Q34076869)

30 July 2017

1 reference

title

Pindolol augmentation of antidepressant treatment: recent contributions from brain imaging studies (English)

1 reference

30 July 2017

Martinez D

1

1 reference

30 July 2017

Broft A

series ordinal

2

1 reference

30 July 2017

Laruelle M

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

30 July 2017

published in

Biological Psychiatry

1 reference

30 July 2017

volume

48

1 reference

30 July 2017

issue

8

1 reference

30 July 2017

page(s)

844-853

1 reference

Pindolol binding to 5-HT1A receptors in the human brain confirmed with positron emission tomography

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

(-)-pindolol and (+/-)-tertatolol affect rat hippocampal 5-HT levels through mechanisms involving not only 5-HT1A, but also 5-HT1B receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Selective activation of postsynaptic 5-HT1A receptors induces rapid antidepressant response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Electrophysiological investigations on the effect of repeated zimelidine administration on serotonergic neurotransmission in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Serotoninergic but not noradrenergic neurons in rat central nervous system adapt to long-term treatment with monoamine oxidase inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Differential effect of gepirone on presynaptic and postsynaptic serotonin receptors: single-cell recording studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Current advances and trends in the treatment of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Réseau de Recherche et d'Expérimentation Psychopharmacologique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

5-Hydroxytryptamine release in dorsal hippocampus of freely moving rats: modulation by pindolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT1A autoreceptor in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Enhancement of fluoxetine-dependent increase of extracellular serotonin (5-HT) levels by (-)-pindolol, an antagonist at 5-HT1A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Physical evidence of the coupling of solubilized 5-HT1A binding sites with G regulatory proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Pindolol increases extracellular 5-HT while inhibiting serotonergic neuronal activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Modulation of dialysate levels of dopamine, noradrenaline, and serotonin (5-HT) in the frontal cortex of freely-moving rats by (-)-pindolol alone and in association with 5-HT reuptake inhibitors: comparative roles of beta-adrenergic, 5-HT1A, and 5-H

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine--I. Effects of acute and long-term administration of tandospirone on serotonin neurotransmission.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Tracer kinetic modeling of the 5-HT1A receptor ligand [carbonyl-11C]WAY-100635 for PET.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Chronic electroconvulsive shock and 5-HT autoreceptor activity in rat brain: an in vivo microdialysis study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Modulation of the firing activity of rat serotonin and noradrenaline neurons by (+/-)pindolol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Characterization of 5-hydroxytryptamine1A properties of flesinoxan: in vivo electrophysiology and hypothermia study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

A rating scale for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Modulation of 5-hydroxytryptamine1A receptor density by nonhydrolyzable GTP analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Pindolol occupancy of 5-HT(1A) receptors measured in vivo using small animal positron emission tomography with carbon-11 labeled WAY 100635

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

(-)-Pindolol, but not buspirone, potentiates the citalopram-induced rise in extracellular 5-hydroxytryptamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

5-HT1A autoreceptors and the mode of action of selective serotonin reuptake inhibitors (SSRI)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

The 5-HT 1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Mixed agonist/antagonist properties of NAN-190 at 5-HT1A receptors: behavioural and in vivo brain microdialysis studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

5-HT receptors: subtypes and second messengers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

[3H]8-OH-DPAT labels a 5-HT site coupled to inhibition of phosphoinositide hydrolysis in the dorsal raphe.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Quantitative autoradiographic characterisation of the binding of [3H]WAY-100635, a selective 5-HT1A receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Characterisation of the binding of [3H]WAY-100635, a novel 5-hydroxytryptamine1A receptor antagonist, to rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Effects of imipramine on raphe nuclei and prefrontal cortex extracellular serotonin levels in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Antidepressant-like action of 8-OH-DPAT, a 5-HT1A agonist, in the learned helplessness paradigm: evidence for a postsynaptic mechanism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Antidepressant-like effects of buspirone mediated by the 5-HT1A post-synaptic receptors in the learned helplessness paradigm.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Differential occupancy of somatodendritic and postsynaptic 5HT(1A) receptors by pindolol: a dose-occupancy study with [11C]WAY 100635 and positron emission tomography in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Serotonin (5-HT) release in the dorsal raphé and ventral hippocampus: raphé control of somatodendritic and terminal 5-HT release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Further evidence for differential affinity states of the serotonin1A receptor in rat hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Pindolol augmentation of treatment-resistant depressed patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Heterogeneity of cortical and hippocampal 5-HT1A receptors: a reappraisal of homogenate binding with 8-[3H]hydroxydipropylaminotetralin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tisssue input functions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

First delineation of 5-HT1A receptors in human brain with PET and [11C]WAY-100635

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

beta-blocker binding to human 5-HT(1A) receptors in vivo and in vitro: implications for antidepressant therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Pharmacological and physicochemical properties of pre-versus postsynaptic 5-hydroxytryptamine1A receptor binding sites in the rat brain: a quantitative autoradiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Displacement of the binding of 5-HT1A receptor ligands to pre- and postsynaptic receptors by (-)pindolol. A comparative study in rodent, primate and human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Application of brain microdialysis to study the pharmacology of the 5-HT1A autoreceptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

How long should pindolol be associated with paroxetine to improve the antidepressant response?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: a controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

Analysis of emission tomographic scan data: limitations imposed by resolution and background

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2800%2900993-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(00)00993-8

1 reference

30 July 2017

1 reference